BioCorRx Inc.: 10-Q filed 2015-05-15

Name: BioCorRx Inc.: 10-Q filed 2015-05-15
Creator: BioCorRx Inc.

What BioCorRx Inc. reported in its quarterly report filed 2015-05-15 (fiscal Q1 2015): 27 published measures, 52 facts as tagged in accession 0001477932-15-003236.

This filing

Form: 10-Q (quarterly report)
Filed: 2015-05-15
Fiscal period: fiscal Q1 2015
Accession: 0001477932-15-003236 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BioCorRx Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2015-03-31	4,024,763	USD
At 2014-12-31	4,083,221	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2015-03-31	3,873,657	USD
At 2014-12-31	3,776,920	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2015-03-31	151,106	USD
At 2014-12-31	306,301	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2015-03-31	21,387	USD
At 2014-12-31	53,120	USD
At 2014-03-31	128,820	USD
At 2013-12-31	108,566	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	-203,174	USD	90
2014-01-01 to 2014-03-31	-1,076,185	USD	90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	-176,314	USD	90
2014-01-01 to 2014-03-31	144	USD	90

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	486	USD	90

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	144,581	USD	90
2014-01-01 to 2014-03-31	34,250	USD	90

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	-14,140	USD	90

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2015-03-31	-8,768,067	USD
At 2014-12-31	-8,564,893	USD

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	19,813,333	shares	90
2014-01-01 to 2014-03-31	20,587,865	shares	90

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2015-03-31	5,716	USD
At 2014-12-31	6,194	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	9,838	USD	90

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2015-03-31	177,470	USD
At 2014-12-31	213,365	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	99,849	USD	90
2014-01-01 to 2014-03-31	73,177	USD	90

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2015-03-31	2,530,368	USD
At 2014-12-31	1,938,001	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2015-03-31	3,672,782	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	283,134	USD	90
2014-01-01 to 2014-03-31	522,555	USD	90

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	11,500	USD	90
2014-01-01 to 2014-03-31	27,700	USD	90

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2015-03-31	149,559,501	shares
At 2014-12-31	146,134,501	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2015-03-31	8,653,613	USD
At 2014-12-31	8,609,059	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2015-03-31	37,725	USD
At 2014-12-31	37,725	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2015-03-31	-32,009	USD
At 2014-12-31	-31,531	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	238,068	USD	90
2014-01-01 to 2014-03-31	460,855	USD	90

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	478	USD	90
2014-01-01 to 2014-03-31	912	USD	90

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	-828	USD	90
2014-01-01 to 2014-03-31	3,896	USD	90

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	15,487	USD	90
2014-01-01 to 2014-03-31	62,543	USD	90

Inspect the source

Entity: BioCorRx Inc. / CIK 0001443863
Captured: 2026-09-20T09:04:22.712Z
SEC response SHA-256: ac5d4257d7a196e773d03095d841b6e99a8b7a937efc54ce0410975e44478703

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001443863.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))